Skip to content
10-K

Annual Report

MOSAIC IMMUNOENGINEERING, INC. CPMV

0001683168-25-002584

← back to feed
Filed
Apr 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 11, 2025 7.24M sh
Shares Diluted FY 2024 · Dec 31, 2024 7.24M sh
Shares Diluted FY 2024 · Dec 31, 2023 7.24M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$497.47K
Cash And Equivalents FY 2024 · Dec 31, 2023 $156.18K
Current Liabilities FY 2024 · Dec 31, 2023 $4.73M
Total Liabilities FY 2024 · Dec 31, 2023 $6.05M
Current Assets FY 2024 · Dec 31, 2023 $179.53K
Total Assets FY 2024 · Dec 31, 2023 $179.53K
Eps Diluted FY 2024 · Dec 31, 2023 −$0.14
Eps Basic FY 2024 · Dec 31, 2023 −$0.14
Rd Expense FY 2024 · Dec 31, 2023 $435.45K
Net Income FY 2024 · Dec 31, 2023 −$1.01M
Operating Income FY 2024 · Dec 31, 2023 −$1.4M
Stockholders Equity FY 2024 · Dec 31, 2022 −$4.88M